Business Operations:

Sector: Healthcare
Industry: Medical Instruments & Supplies

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Revenue projections:

ISRG is projected to see lower revenues than in the previous year, a trend that usually concerns investors. Declining revenues often harm a company's profitability, leading investors to exercise caution as they weigh the potential risks of continued financial downturns.

Financial Ratios:

currentRatio	4.963000
forwardPE	32.416138
debtToEquity	0.000000
earningsGrowth	0.265000
revenueGrowth	0.185000
grossMargins	0.666790
operatingMargins	0.336030
trailingEps	8.700000
forwardEps	12.091200

ISRG's current ratio of 4.963 highlights the company's ability to easily cover its short-term debt using its available cash and assets. This indicates a strong liquidity position, ensuring ISRG is unlikely to face difficulties in meeting immediate financial obligations.
ISRG's positive earnings and revenue growth signal the company's business is on track for further expansion. These strong financial trends suggest that ISRG will continue to grow its operations, driven by increasing profits and revenue.
Intuitive Surgical, Inc.'s positive gross and operating margins suggest that the company is operating profitably. These strong margins indicate effective cost management and revenue generation, contributing to a solid financial foundation.
ISRG's forward EPS surpassing its trailing EPS signals that the company is anticipated to be more profitable this year than last. This growth expectation highlights ISRG's potential for increased earnings and a stronger financial performance in the upcoming year.

Price projections:

ISRG's price has frequently been situated near the lower end of analysts' projections. This trend indicates that the stock is struggling to meet expectations, which could signal a need for improvements in performance or investor confidence.

Insider Transactions:

37 sales transactions of Intuitive Surgical, Inc. were conducted, with market price at 467.6564867174303.During the review period, no sell transactions were executed.ISRG's current price levels are seeing more buying activity than selling, which might indicate a bullish sentiment. Investors appear to be confident, interpreting the buying trend as a sign of positive expectations for the stock's future performance.

Recommendation changes over time:

The recent buy bias for Intuitive Surgical, Inc. from analysts signals strong confidence in the stock's potential. This positive sentiment could encourage investors to see Intuitive Surgical, Inc. as a smart place to invest their money, especially those looking for stable, long-term returns in a well-established company.